234 related articles for article (PubMed ID: 15220007)
21. Molecular and biochemical characterization of JAK3 deficiency in a patient with severe combined immunodeficiency over 20 years after bone marrow transplantation: implications for treatment.
Bozzi F; Lefranc G; Villa A; Badolato R; Schumacher RF; Khalil G; Loiselet J; Bresciani S; O'Shea JJ; Vezzoni P; Notarangelo LD; Candotti F
Br J Haematol; 1998 Sep; 102(5):1363-6. PubMed ID: 9753072
[TBL] [Abstract][Full Text] [Related]
22. Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3.
Brown MP; Nosaka T; Tripp RA; Brooks J; van Deursen JM; Brenner MK; Doherty PC; Ihle JN
Blood; 1999 Sep; 94(6):1906-14. PubMed ID: 10477719
[TBL] [Abstract][Full Text] [Related]
23. Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains.
Chen M; Cheng A; Candotti F; Zhou YJ; Hymel A; Fasth A; Notarangelo LD; O'Shea JJ
Mol Cell Biol; 2000 Feb; 20(3):947-56. PubMed ID: 10629052
[TBL] [Abstract][Full Text] [Related]
24. Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model.
Notarangelo LD; Giliani S; Mazza C; Mella P; Savoldi G; Rodriguez-Pérez C; Mazzolari E; Fiorini M; Duse M; Plebani A; Ugazio AG; Vihinen M; Candotti F; Schumacher RF
Immunol Rev; 2000 Dec; 178():39-48. PubMed ID: 11213805
[TBL] [Abstract][Full Text] [Related]
25. Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a model.
Notarangelo LD; Giliani S; Mella P; Schumacher RF; Mazza C; Savoldi G; Rodriguez-Pérez C; Badolato R; Mazzolari E; Porta F; Candotti F; Ugazio AG
Immunobiology; 2000 Aug; 202(2):106-19. PubMed ID: 10993286
[TBL] [Abstract][Full Text] [Related]
26. Genomic structure and promoter region of the murine Janus-family tyrosine kinase, Jak3.
Gurniak CB; Thomis DC; Berg LJ
DNA Cell Biol; 1997 Jan; 16(1):85-94. PubMed ID: 9022047
[TBL] [Abstract][Full Text] [Related]
27. Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway.
Candotti F; O'Shea JJ; Villa A
Springer Semin Immunopathol; 1998; 19(4):401-15. PubMed ID: 9618765
[No Abstract] [Full Text] [Related]
28. A new modality for immunosuppression: targeting the JAK/STAT pathway.
O'Shea JJ; Pesu M; Borie DC; Changelian PS
Nat Rev Drug Discov; 2004 Jul; 3(7):555-64. PubMed ID: 15232577
[No Abstract] [Full Text] [Related]
29. Immunodeficiencies caused by genetic defects in protein kinases.
Notarangelo LD
Curr Opin Immunol; 1996 Aug; 8(4):448-53. PubMed ID: 8794005
[TBL] [Abstract][Full Text] [Related]
30. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer.
Bunting KD; Sangster MY; Ihle JN; Sorrentino BP
Nat Med; 1998 Jan; 4(1):58-64. PubMed ID: 9427607
[TBL] [Abstract][Full Text] [Related]
31. Zebrafish Model of Severe Combined Immunodeficiency (SCID) Due to JAK3 Mutation.
Basheer F; Lee E; Liongue C; Ward AC
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291730
[TBL] [Abstract][Full Text] [Related]
32. A novel mutant gammac chain from a patient with typical phenotype of X-linked severe combined immunodeficiency (SCID) has partial signalling function for mediating IL-2 and IL-4 receptor action.
Kumaki S; Ochs HD; Kuropatwinski KK; Konno T; Timour MS; Cosman D; Baumann H
Clin Exp Immunol; 1999 Feb; 115(2):356-61. PubMed ID: 9933465
[TBL] [Abstract][Full Text] [Related]
33. Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency.
Sato T; Okano T; Tanaka-Kubota M; Kimura S; Miyamoto S; Ono S; Yamashita M; Mitsuiki N; Takagi M; Imai K; Kajiwara M; Ebato T; Ogata S; Oda H; Ohara O; Kanegane H; Morio T
Pediatr Int; 2016 Oct; 58(10):1076-1080. PubMed ID: 27593409
[TBL] [Abstract][Full Text] [Related]
34. Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.
Roberts JL; Lengi A; Brown SM; Chen M; Zhou YJ; O'Shea JJ; Buckley RH
Blood; 2004 Mar; 103(6):2009-18. PubMed ID: 14615376
[TBL] [Abstract][Full Text] [Related]
35. Cytokines and immunodeficiency diseases.
Leonard WJ
Nat Rev Immunol; 2001 Dec; 1(3):200-8. PubMed ID: 11905829
[TBL] [Abstract][Full Text] [Related]
36. Complete genomic organization of the human JAK3 gene and mutation analysis in severe combined immunodeficiency by single-strand conformation polymorphism.
Schumacher RF; Mella P; Badolato R; Fiorini M; Savoldi G; Giliani S; Villa A; Candotti F; Tampalini A; O'Shea JJ; Notarangelo LD
Hum Genet; 2000 Jan; 106(1):73-9. PubMed ID: 10982185
[TBL] [Abstract][Full Text] [Related]
37. A novel mutation in the JH4 domain of JAK3 causing severe combined immunodeficiency complicated by vertebral osteomyelitis.
Qamar F; Junejo S; Qureshi S; Seleman M; Bainter W; Massaad M; Chou J; Geha RS
Clin Immunol; 2017 Oct; 183():198-200. PubMed ID: 28917720
[TBL] [Abstract][Full Text] [Related]
38. Stat5a/b are essential for normal lymphoid development and differentiation.
Yao Z; Cui Y; Watford WT; Bream JH; Yamaoka K; Hissong BD; Li D; Durum SK; Jiang Q; Bhandoola A; Hennighausen L; O'Shea JJ
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1000-5. PubMed ID: 16418296
[TBL] [Abstract][Full Text] [Related]
39. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals.
Chen M; Cheng A; Chen YQ; Hymel A; Hanson EP; Kimmel L; Minami Y; Taniguchi T; Changelian PS; O'Shea JJ
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6910-5. PubMed ID: 9192665
[TBL] [Abstract][Full Text] [Related]
40. X-linked SCID and other defects of cytokine pathways.
Uribe L; Weinberg KI
Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
